What Is the Quality of Pre-Dialysis Healthcare in the Czech Republic?
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11120%2F12%3A43907186" target="_blank" >RIV/00216208:11120/12:43907186 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/68081740:_____/12:00382699 RIV/00064173:_____/12:43907186 RIV/00216224:14330/12:00080256
Výsledek na webu
<a href="http://dx.doi.org/10.1159/000336176" target="_blank" >http://dx.doi.org/10.1159/000336176</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1159/000336176" target="_blank" >10.1159/000336176</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
What Is the Quality of Pre-Dialysis Healthcare in the Czech Republic?
Popis výsledku v původním jazyce
The PREPARE study (PRE-dialysis healthcare in PAtients initiating Renal rEplacement therapy and its consequences) evaluates the quality of pre-dialysis healthcare in patients commencing dialysis treatment in the Czech Republic. Methods: 48% of Czech dialysis centers participating in this prospective multicenter observational study provided data on all consecutive patients starting renal replacement therapy during 24 weeks. Results: 68% out of 303 patients had nephrological pre-dialysis care lasting >6 months (57% diabetics). Peritoneal dialysis (PD) was chosen by 11.2%. 23.6% of patients were receiving erythropoiesis-stimulating agents while the mean hemoglobin level was 98.3 +/- 15.6 g/l. 36.1% of patients were taking phosphate binders while serum phosphates reached 1.90 +/- 0.61 mmol/l. 64.4% of patients had a functional arteriovenous fistula or PD catheter. 91.8% of the patients felt they were well informed about hemodialysis and 51.6% about PD. Physicians reported poor compliance o
Název v anglickém jazyce
What Is the Quality of Pre-Dialysis Healthcare in the Czech Republic?
Popis výsledku anglicky
The PREPARE study (PRE-dialysis healthcare in PAtients initiating Renal rEplacement therapy and its consequences) evaluates the quality of pre-dialysis healthcare in patients commencing dialysis treatment in the Czech Republic. Methods: 48% of Czech dialysis centers participating in this prospective multicenter observational study provided data on all consecutive patients starting renal replacement therapy during 24 weeks. Results: 68% out of 303 patients had nephrological pre-dialysis care lasting >6 months (57% diabetics). Peritoneal dialysis (PD) was chosen by 11.2%. 23.6% of patients were receiving erythropoiesis-stimulating agents while the mean hemoglobin level was 98.3 +/- 15.6 g/l. 36.1% of patients were taking phosphate binders while serum phosphates reached 1.90 +/- 0.61 mmol/l. 64.4% of patients had a functional arteriovenous fistula or PD catheter. 91.8% of the patients felt they were well informed about hemodialysis and 51.6% about PD. Physicians reported poor compliance o
Klasifikace
Druh
J<sub>x</sub> - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
CEP obor
ED - Fyziologie
OECD FORD obor
—
Návaznosti výsledku
Projekt
—
Návaznosti
N - Vyzkumna aktivita podporovana z neverejnych zdroju
Ostatní
Rok uplatnění
2012
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Kidney & Blood Press Research
ISSN
1420-4096
e-ISSN
—
Svazek periodika
35
Číslo periodika v rámci svazku
6
Stát vydavatele periodika
CH - Švýcarská konfederace
Počet stran výsledku
8
Strana od-do
417-424
Kód UT WoS článku
000314461100004
EID výsledku v databázi Scopus
—